Boston Partners - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 167 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Boston Partners ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$531,000
-82.5%
70,003
-85.4%
0.00%
-50.0%
Q4 2019$3,032,000
+156.5%
479,636
+59.0%
0.00%0.0%
Q3 2019$1,182,000
-0.8%
301,603
+22.5%
0.00%0.0%
Q2 2019$1,192,000
-48.6%
246,266
-13.0%
0.00%
-33.3%
Q1 2019$2,318,000
+50.0%
283,044
+1.3%
0.00%
+50.0%
Q4 2018$1,545,000279,3780.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders